Attovia Therapeutics, Inc. (ATTO) vs Varex Imaging Corporation (VREX)
A side-by-side comparison of Attovia Therapeutics, Inc. and Varex Imaging Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$17.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VREX
Varex Imaging Corporation
$18.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ATTO vs VREX
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)VREX +48.9% (+48.9%/yr)VREX compounded faster over this window
ATTO VREX
ATTO vs VREX: by the numbers
- •VREX is the larger company ($778M vs $753M market cap).
- •VREX is profitable (2.55% net margin) while ATTO runs a net loss (-4490.89%).
Metrics side by side
Valuation
| Metric | ATTO | VREX |
|---|---|---|
| P/E ratio | N/A | 35.24 |
| Forward P/E | N/A | 17.27 |
| P/S ratio | N/A | 0.90 |
| P/B ratio | N/A | 1.57 |
| EV / EBITDA | N/A | 10.58 |
Profitability
| Metric | ATTO | VREX |
|---|---|---|
| Gross margin | 40.44% | 34.32% |
| Operating margin | -4974.74% | -3.29% |
| Net margin | -4490.89% | 2.55% |
| ROE | -40.21% | 4.45% |
| ROIC | -42.83% | 6.30% |
Growth (annualized)
| Metric | ATTO | VREX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.57% |
| Total return CAGR (5Y) | N/A | -8.41% |
Frequently asked
- Is ATTO or VREX more profitable?
- VREX runs the higher net margin — ATTO at -4490.89% versus VREX at 2.55%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.